SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-21-098134
Filing Date
2021-03-29
Accepted
2021-03-29 15:05:59
Documents
1
Effectiveness Date
2021-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 POS d167465ds8pos.htm S-8 POS 17298
  Complete submission text file 0001193125-21-098134.txt   18316
Mailing Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617
Business Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Filer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-234621 | Film No.: 21781296
SIC: 2834 Pharmaceutical Preparations